TC BioPharm (Holdings) plc - Warrants
TC BioPharm (Holdings) plc - Warrants
Share · US87807D1110 · TCBPW (XNAS)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - 0,00 % -41,18 % -62,64 % -13,04 % -98,93 %

Company Profile for TC BioPharm (Holdings) plc - Warrants Share

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its products pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; ImmuniStim, an unmodified cell therapy to treat COVID-19; TCB009 for the GI-tract cancer treatment; and TCB005/TCB006 that are allogeneic co-stimulatory GD-T CAR pre-clinical drug candidates would target antigens expressed on various solid tumor types. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

Company Data

Name TC BioPharm (Holdings) plc - Warrants
Company TC Biopharm (Holdings) Plc
Symbol TCBPW
Website https://www.tcbiopharm.com
Primary Exchange XNAS NASDAQ
ISIN US87807D1110
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Bryan Leland Kobel
Country United Kingdom
Currency USD
Employees 0,0 T
Address Maxim 1, ML1 4WR Motherwell

Ticker Symbols

Name Symbol
NASDAQ TCBPW

More Shares

Investors who TC BioPharm (Holdings) plc - Warrants hold also have the following shares in their portfolio:
COLOR STAR TECHNOLOGIESLOGY CO LTDNARY SHARES
COLOR STAR TECHNOLOGIESLOGY CO LTDNARY SHARES Share
I2-I.G.E.E.E. DLA
I2-I.G.E.E.E. DLA ETF
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025